American College of Neuropsychopharmacology (ACNP)

January 12-15 2026, Nassau, Bahamas

Neuroscience

ACNP

Nassau

Poster

Efficacy of Xanomeline and Trospium Chloride Across Symptom Domains in Adults With Schizophrenia: Results From the 52-Week, Open-Label EMERGENT-5 Clinical Trial

Hicks T et al.

foot note heading
U.S. Medical Information & Services

Access medical information and resources for U.S. healthcare professionals.

Medical Information Online  External new tab
Medical Information Contact Center

800-321-1335 (toll free U.S. only)

Mon - Fri, 8am - 5pm ET

Report Adverse Events or Product Quality Complaints

800-721-5072 (toll free U.S. only)

For outside the U.S., visit our global site to report Adverse Events, Product Quality Complaints or submit a Medical Information inquiry.

Follow us

      

Legal notice  External new tab

Privacy notice center  External new tab

Your Privacy Choices

Trademarks  External new tab

© 2025 Bristol-Myers Squibb Company
BMS Medical is a trademark of Bristol-Myers Squibb Company
NO-US-2500378 12/25